Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Mar;49(3):291–300. doi: 10.1038/bjc.1984.46

Effect of the nitroimidazole Ro 03-8799 on the activity of chemotherapeutic agents against a murine tumour in vivo.

P W Sheldon, P Gibson
PMCID: PMC1976734  PMID: 6704303

Abstract

The effect of the 2-nitroimidazole Ro 03-8799 (8799) on the activity of 11 chemotherapeutic agents against the anaplastic MT tumour in mice has been determined by soft agar cloning. The 8799, whilst producing little cytotoxicity by itself, potentiated the cytotoxic actions of the alkylating agents melphalan and cyclophosphamide, and the nitrosoureas BCNU, CCNU and MeCCNU. This potentiation was influenced by the time interval between the administration of 8799 and the chemotherapeutic agents, and also by the site of tumour implantation. However, 8799 did not potentiate the cytotoxicities of the compounds CBDCA, cisplatin, adriamycin, vincristine, 5-fluorouracil and bleomycin. A review is included of the reported in vivo effects of nitroimidazoles on the chemotherapeutic agents investigated here.

Full text

PDF
291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clement J. J., Gorman M. S., Wodinsky I., Catane R., Johnson R. K. Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole. Cancer Res. 1980 Nov;40(11):4165–4172. [PubMed] [Google Scholar]
  2. Clement J. J., Johnson R. K. Evaluation of radiosensitizers in combination with chemotherapeutic agents in solid tumors. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):631–634. doi: 10.1016/0360-3016(82)90700-3. [DOI] [PubMed] [Google Scholar]
  3. Clutterbuck R. D., Millar J. L., McElwain T. J. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts. Am J Clin Oncol. 1982 Feb;5(1):73–78. [PubMed] [Google Scholar]
  4. Hill R. P., Stanley J. A. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents. Cancer Res. 1975 May;35(5):1147–1153. [PubMed] [Google Scholar]
  5. Hirst D. G., Brown J. M., Hazlehurst J. L. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain. Br J Cancer. 1982 Jul;46(1):109–116. doi: 10.1038/bjc.1982.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hirst D. G., Brown J. M. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):639–642. doi: 10.1016/0360-3016(82)90702-7. [DOI] [PubMed] [Google Scholar]
  7. Kelly J. P., Hannam T. W., Giles G. R. The cytocidal action of metronidazole in combination with other antineoplastic agents. Cancer Treat Rev. 1979 Jun;6 (Suppl):53–61. doi: 10.1016/s0305-7372(79)80013-4. [DOI] [PubMed] [Google Scholar]
  8. Law M. P., Hirst D. G., Brown J. M. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide. Br J Cancer. 1981 Aug;44(2):208–218. doi: 10.1038/bjc.1981.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Martin W. M., McNally N. J., De Ronde J. Enhancement of the effect of cytotoxic drugs by radiosensitizers. Br J Cancer. 1981 Jun;43(6):756–766. doi: 10.1038/bjc.1981.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McNally N. J. Enhancement of chemotherapy agents. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):593–598. doi: 10.1016/0360-3016(82)90691-5. [DOI] [PubMed] [Google Scholar]
  11. McNally N. J., Hinchliffe M., de Ronde J. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole. Br J Cancer. 1983 Aug;48(2):271–278. doi: 10.1038/bjc.1983.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mulcahy R. T. Chemical properties of nitrosoureas: implications for interaction with misonidazole. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):599–602. doi: 10.1016/0360-3016(82)90692-7. [DOI] [PubMed] [Google Scholar]
  13. Mulcahy R. T., Siemann D. W., Sutherland R. M. In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU. Br J Cancer. 1981 Jan;43(1):93–99. doi: 10.1038/bjc.1981.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Murray D., Meyn R. E. Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo. Br J Cancer. 1983 Feb;47(2):195–203. doi: 10.1038/bjc.1983.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pedersen J. E., Barron G., Meeker B. E. The value of combining the radiosensitizer misonidazole with cyclophosphamide in treating the murine Lewis lung tumor. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):651–653. doi: 10.1016/0360-3016(82)90705-2. [DOI] [PubMed] [Google Scholar]
  16. Randhawa V. S., Stewart F. A., Denekamp J. Chemosensitization of mouse tumors by misonidazole. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):671–674. doi: 10.1016/0360-3016(82)90710-6. [DOI] [PubMed] [Google Scholar]
  17. Sheldon P. W., Batten E. L., Adams G. E. Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds. Br J Cancer. 1982 Oct;46(4):525–531. doi: 10.1038/bjc.1982.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sheldon P. W., Batten E. L. Potentiation in vivo of melphalan activity by nitroimidazole compounds. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):635–637. doi: 10.1016/0360-3016(82)90701-5. [DOI] [PubMed] [Google Scholar]
  19. Siemann D. W. In vivo combination of misonidazole and the chemotherapeutic agent CCNU. Br J Cancer. 1981 Mar;43(3):367–377. doi: 10.1038/bjc.1981.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Siemann D. W., Mulcahy R. T. Cell survival recovery kinetics in the KHT sarcoma following treatment with five alkylating agents and misonidazole. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):619–622. doi: 10.1016/0360-3016(82)90697-6. [DOI] [PubMed] [Google Scholar]
  21. Sladek N. E. Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo. Cancer Res. 1973 Jun;33(6):1150–1158. [PubMed] [Google Scholar]
  22. Stephens T. C., Courtenay V. D., Mills J., Peacock J. H., Rose C. M., Spooner D. Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole. Br J Cancer. 1981 Apr;43(4):451–457. doi: 10.1038/bjc.1981.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sutherland R. M., Eddy H. A., Bareham B., Reich K., Vanantwerp D. Resistance to adriamycin in multicellular spheroids. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1225–1230. doi: 10.1016/0360-3016(79)90643-6. [DOI] [PubMed] [Google Scholar]
  24. Tannock I. F. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU. Br J Cancer. 1980 Dec;42(6):871–880. doi: 10.1038/bjc.1980.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tannock I. F. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin. Br J Cancer. 1980 Dec;42(6):861–870. doi: 10.1038/bjc.1980.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Twentyman P. R. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721. Br J Cancer. 1981 Jun;43(6):745–755. doi: 10.1038/bjc.1981.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Twentyman P. R., Workman P. Chemosensitization by lipophilic nitroimidazoles. Br J Cancer. 1983 Jul;48(1):17–26. doi: 10.1038/bjc.1983.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Twentyman P. R., Workman P. The effect of radiosensitizer pretreatment on the response of the RIF-1 mouse sarcoma to cytotoxic drugs. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):611–613. doi: 10.1016/0360-3016(82)90695-2. [DOI] [PubMed] [Google Scholar]
  29. Workman P., Twentyman P. R. Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: structure-activity relationships. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):623–626. doi: 10.1016/0360-3016(82)90698-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES